Endolymphatic sac-vein decompression for intractable Meniere's disease: Long term treatment results
Endolymphatic sac-vein decompression for intractable Meniere's disease: Long term treatment results
复制标题
DOI:
10.1016/s0194-5998(03)00084-6
复制
发表时间:
2003-04-01
影响因子:
3.4
通讯作者:
Kartush, JM
中科院分区:
文献类型:
--
作者:
Ostrowski, VB;Kartush, JM
OBJECTIVES: We sought to determine the long-term efficacy of endolymphatic sac-vein decompression surgery on patients with classic Meniere's disease.STUDY DESIGN AND SETTING: Using the 1995 American Academy of Otolaryngology-Head and Neck Surgery Committee on Hearing and Equilibrium criteria, starting stage, functional level, vertigo class, and hearing results were addressed. We studied 68 patients with classic Meniere's disease from a tertiary, private otology-neurotology practice. Patient data were gathered by retrospective chart review, questionnaire, and patient interview. All patients underwent endolymphatic sac-vein decompression with an average follow-up period of 55 months.RESULTS: Median functional level before surgery was level 4, improving to level 2 after surgery. Eighty-one percent of patients showed improvement in functional level, 12% remained stable, and 7% declined. Long-term vertigo control was 47% in class A, 25% in class B, 9% in class C, 3% in class D, and 16% in class F. Twenty percent of patients were in hearing stage I Meniere's disease; 31%, stage II; 44%, stage III; and 5%, stage IV. Eighteen percent of patients showed improvement in hearing class, 64% were stable, and 18% declined.CONCLUSION: Endolymphatic sac-vein decompression surgery is a safe, nondestructive surgical option for Meniere's disease that offers durable control of vertigo and stabilization of hearing for the majority of symptomatic patients.SIGNIFICANCE: The beneficial long-term outcome of the andolymphafic sac-vein decompression supports its continued use as a first-line treatment option in intractable Meniere's disease.